Literature DB >> 9285671

Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.

S Di Benedetto1.   

Abstract

The efficacy and safety of quinidine, as a rapid oral loading therapy, and propafenone in the conversion of atrial fibrillation of <6 months duration to sinus rhythm were compared. Quinidine was more efficacious and as well tolerated as propafenone.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9285671     DOI： 10.1016/s0002-9149(97)00408-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.

Authors:  Giuseppe Boriani; Cristian Martignani; Mauro Biffi; Alessandro Capucci; Angelo Branzi
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival.

Authors:  Shaan Khurshid; Simon Akerman; Jonathan P Man; Gregory Supple; Sanjay Dixit; Andrew E Epstein; Francis E Marchlinski; David S Frankel
Journal:  J Interv Card Electrophysiol       Date:  2015-01-27       Impact factor: 1.900

3.  Quinidine for Pharmacological Cardioversion of Long-lasting Atrial Fibrillation.

Authors:  Matteo Baroni; Antoine Kheir; Margherita Manfredi; Francesco Pattarino; Flavio Doni
Journal:  J Atr Fibrillation       Date:  2011-07-15

Review 4.  Cost effectiveness of therapies for atrial fibrillation. A review.

Authors:  M P Teng; L E Catherwood; D P Melby
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

5.  Cytochrome P450-2D6 Genotype Definition May Improve Therapy for Paroxysmal Atrial Fibrillation A Case of Syncope Following "Pill-in-the-Pocket" Quinidine plus Propafenone.

Authors:  Harry W Daniell M D
Journal:  J Atr Fibrillation       Date:  2014-02-28

6.  Quinidine for pharmacological cardioversion of atrial fibrillation: a retrospective analysis in 501 consecutive patients.

Authors:  Bernhard Schwaab; Alexander Katalinic; Uta Maria Böge; Jürgen Loh; Peter Blank; Tatjana Kölzow; Dirk Poppe; Hendrik Bonnemeier
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.